Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Recall Of Medtronic Guidewire High-Risk Class I, FDA Says
Jul 02 2021
•
By
Shawn M. Schmitt
More from Recalls
More from Policy & Regulation